z-logo
open-access-imgOpen Access
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
Author(s) -
Jineta Banerjee,
Jan M. Friedman,
Laura J. Klesse,
Kaleb Yohay,
Justin T. Jordan,
Scott R. Plotkin,
Robert J. Allaway,
Jaishri O. Blakeley
Publication year - 2022
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1016/j.gim.2022.10.007
Subject(s) - medicine , cohort , neurofibromatosis , covid-19 , population , cohort study , neurofibromatosis type 2 , pediatrics , disease , pathology , environmental health , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom